✦ LIBER ✦

BCR–ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia

✍ Scribed by Burke, B A; Carroll, M

Book ID: 109887398
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 521 KB
Volume: 24
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2010.67

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bcr-Abl and inhibition of apoptosis in c

Bcr-Abl and inhibition of apoptosis in chronic myelogenous leukemia cells

✍ J. L. Fernandez-Luna 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 154 KB

Analysis of BCR-ABL mRNA in chronic myel

Analysis of BCR-ABL mRNA in chronic myelogenous leukemia patients and identification of a new BCR-related sequence in human DNA

✍ Christophe Marcelle; Robert P. Gale; Miron Prokocimer; Alan Berrebi; Hélène Merl 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 674 KB

The Philadelphia chromosome is present in more than 95% of chronic myelogenous leukemia patients and in up to 25% of patients with acute lymphocytic leukemia. The major consequence of the aberration is the fusion of the ABL and BCR genes. The position of the breakpoint on chromosome 22 determines wh

Simultaneous detection of JAK2 V617F mut

Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia

✍ Monika Ribeiro Mello de Conchon; Juliana Lima Costa; Mafalda Megumi Yoshinaga No 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 191 KB

Microtitre-well hybridization and immuno

Microtitre-well hybridization and immunofluorometric detection of specific BCR-ABL transcripts in chronic myelogenous leukemia

✍ S. Bortolin; T.K. Christopoulos 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Flow cytometric assay of phosphotyrosine

Flow cytometric assay of phosphotyrosine levels in Bcr-Abl-positive chronic myelogenous leukemias: a potential prognostic marker

✍ Xuemei Sun; Jianyong Li; Junhao Chen; Dong Li; Leilei Chen; Wei Xu; Yonggong Yan 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 361 KB

O37 BCR-ABL kinase domain mutations and

O37 BCR-ABL kinase domain mutations and clonal evolution as major causes of resistance to targeted therapy in chronic myelogenous leukemia

✍ H. Andrikovics; N. Meggyesi; S. Lueff; A. Batai; E. Adam; A. Kozma; G. Halm; S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Hb-Hana family is the first described example, where partial glutathione reductase deficiency represents a modifying factor of clinical manifestation of unstable hemoglobinopathy. Grant support: MSM 6198959205 and MSM 6198959216. O35 A prognostic impact of transfusion dependency on survival of pati